246 related articles for article (PubMed ID: 26835975)
21. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
22. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme.
Sørum R; Hofvind S; Skaane P; Haldorsen T
Breast; 2010 Dec; 19(6):499-505. PubMed ID: 21071225
[TBL] [Abstract][Full Text] [Related]
23. Five-year risk of interval-invasive second breast cancer.
Lee JM; Buist DS; Houssami N; Dowling EC; Halpern EF; Gazelle GS; Lehman CD; Henderson LM; Hubbard RA
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25904721
[TBL] [Abstract][Full Text] [Related]
24. Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and Norway.
Suhrke P; Mæhlen J; Zahl PH
Breast J; 2012; 18(6):549-56. PubMed ID: 23002918
[TBL] [Abstract][Full Text] [Related]
25. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.
Allison KH; Abraham LA; Weaver DL; Tosteson AN; Nelson HD; Onega T; Geller BM; Kerlikowske K; Carney PA; Ichikawa LE; Buist DS; Elmore JG
Cancer; 2015 May; 121(9):1369-78. PubMed ID: 25603785
[TBL] [Abstract][Full Text] [Related]
26. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects.
Beckmann K; Duffy SW; Lynch J; Hiller J; Farshid G; Roder D
J Med Screen; 2015 Sep; 22(3):127-35. PubMed ID: 25896926
[TBL] [Abstract][Full Text] [Related]
27. Study "guesstimated" how many cancers would have occurred without mammography screening.
Kopans DB
BMJ; 2014 Nov; 349():g6824. PubMed ID: 25424500
[No Abstract] [Full Text] [Related]
28. The impact of mammographic screening on the surgical management of breast cancer.
James TA; Wade JE; Sprague BL
J Surg Oncol; 2016 Apr; 113(5):496-500. PubMed ID: 26799535
[TBL] [Abstract][Full Text] [Related]
29. Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?
Passaperuma K; Warner E; Hill KA; Gunasekara A; Yaffe MJ
J Clin Oncol; 2010 Aug; 28(23):3779-83. PubMed ID: 20625126
[TBL] [Abstract][Full Text] [Related]
30. Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women.
Chay WY; Ong WS; Tan PH; Jie Leo NQ; Ho GH; Wong CS; Chia KS; Chow KY; Tan M; Ang P
Breast Cancer Res; 2012 Jan; 14(1):R19. PubMed ID: 22289271
[TBL] [Abstract][Full Text] [Related]
31. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
32. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
Coldman A; Phillips N
CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
[TBL] [Abstract][Full Text] [Related]
33. Effect of three decades of screening mammography on breast-cancer incidence.
Bleyer A; Welch HG
N Engl J Med; 2012 Nov; 367(21):1998-2005. PubMed ID: 23171096
[TBL] [Abstract][Full Text] [Related]
34. Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening.
Hofvind S; Iversen BF; Eriksen L; Styr BM; Kjellevold K; Kurz KD
Acta Radiol; 2011 Jun; 52(5):481-7. PubMed ID: 21498306
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer in Singapore: some perspectives.
Jara-Lazaro AR; Thilagaratnam S; Tan PH
Breast Cancer; 2010; 17(1):23-8. PubMed ID: 19701678
[TBL] [Abstract][Full Text] [Related]
36. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.
van Luijt PA; Fracheboud J; Heijnsdijk EA; den Heeten GJ; de Koning HJ;
Eur J Cancer; 2013 Nov; 49(16):3517-25. PubMed ID: 23871248
[TBL] [Abstract][Full Text] [Related]
37. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
38. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
[TBL] [Abstract][Full Text] [Related]
39. Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study.
de Glas NA; de Craen AJ; Bastiaannet E; Op 't Land EG; Kiderlen M; van de Water W; Siesling S; Portielje JE; Schuttevaer HM; de Bock GT; van de Velde CJ; Liefers GJ
BMJ; 2014 Sep; 349():g5410. PubMed ID: 25224469
[TBL] [Abstract][Full Text] [Related]
40. StatBite: Percent change in DCIS, invasive breast cancer, and mammography.
J Natl Cancer Inst; 2011 Mar; 103(6):457. PubMed ID: 21393608
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]